The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer

U. Banerji, D.R. Camidge, H.M.W. Verheul, R. Agarwal, D. Sarker, S.B. Kaye, I.M.E. Desar, J.N.H. Timmer-Bonte, S.G. Eckhardt, K.D. Lewis, K.H. Brown, M.V. Cantarini, C. Morris, S.M.A. George, P.D. Smith, C.M.L. van Herpen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1613-1623
JournalClinical Cancer Research
Issue number5
Publication statusPublished - 2010

Cite this